{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:10:51Z","timestamp":1780675851900,"version":"3.54.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":3237,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["11729"],"award-info":[{"award-number":["11729"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["13279"],"award-info":[{"award-number":["13279"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medizinische Universit\u00e4t Graz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ajpath.2010.10.008","type":"journal-article","created":{"date-parts":[[2011,1,29]],"date-time":"2011-01-29T04:17:08Z","timestamp":1296274628000},"page":"699-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Platelet-Activating Factor Blockade Inhibits the T-Helper Type 17 Cell Pathway and Suppresses Psoriasis-Like Skin Disease in K5.hTGF-\u03b21 Transgenic Mice"],"prefix":"10.1016","volume":"178","author":[{"given":"Tej Pratap","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Huettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Koefeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlinde","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Bambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Wallbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2010.10.008_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0163-7827(99)00016-8","article-title":"Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice","volume":"39","author":"Ishii","year":"2000","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.ajpath.2010.10.008_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0006-291X(85)90590-X","article-title":"Structural identification of platelet activating factor in psoriatic scale","volume":"126","author":"Mallet","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2010.10.008_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1084\/jem.20011450","article-title":"Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression","volume":"195","author":"Walterscheid","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2010.10.008_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10555-007-9092-9","article-title":"Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor","volume":"26","author":"Melnikova","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ajpath.2010.10.008_bib5","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4049\/jimmunol.161.4.1954","article-title":"Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis","volume":"161","author":"Pei","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib6","first-page":"4777","article-title":"Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A","volume":"54","author":"Maggi","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2010.10.008_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1749-0774.2003.tb00139.x","article-title":"The effects of an autocrine loop mediated by platelet-activating factor (PAF) in HEC-1A cells are reverted by uteroglobin","volume":"16","author":"Peri","year":"2003","journal-title":"Hum Cell"},{"key":"10.1016\/j.ajpath.2010.10.008_bib8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1365-2133.1996.tb07943.x","article-title":"Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation","volume":"134","author":"Izaki","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1523-1747.ep12497850","article-title":"Role of the microcirculation in the treatment and pathogenesis of psoriasis","volume":"78","author":"Braverman","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01534593","article-title":"Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue","volume":"18","author":"Andersen","year":"1994","journal-title":"Inflammation"},{"key":"10.1016\/j.ajpath.2010.10.008_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/BF01966522","article-title":"Identification and quantitation of PAF from psoriatic scales","volume":"21","author":"Ramesha","year":"1987","journal-title":"Agents Actions"},{"key":"10.1016\/j.ajpath.2010.10.008_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/1523-1747.ep12298295","article-title":"Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes","volume":"107","author":"Travers","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/1523-1747.ep12326581","article-title":"Identification of functional platelet-activating factor receptors on human keratinocytes","volume":"105","author":"Travers","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib14","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/sj.emboj.7600183","article-title":"Latent TGF\u03b21 overexpression in keratinocytes results in a severe psoriasis-like skin disorder","volume":"23","author":"Li","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2010.10.008_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jid.2009.252","article-title":"A role for TGF\u03b2 signaling in the pathogenesis of psoriasis","volume":"130","author":"Han","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib16","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.4049\/jimmunol.0903719","article-title":"8-Methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23\/Th17 axis and induction of Foxp3(+) regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder","volume":"184","author":"Singh","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/187152809788681010","article-title":"Platelet activating factor\/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases","volume":"8","author":"Edwards","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.ajpath.2010.10.008_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib19","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awp289","article-title":"Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis","volume":"132","author":"Brucklacher-Waldert","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2010.10.008_bib20","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.imlet.2009.10.006","article-title":"IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4(+) T cell population of rheumatoid arthritis patients","volume":"127","author":"Heo","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ajpath.2010.10.008_bib22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2796.2009.02099.x","article-title":"Th17 cells in rheumatoid arthritis and systemic lupus erythematosus","volume":"265","author":"Pernis","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.ajpath.2010.10.008_bib23","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.smim.2007.10.007","article-title":"Th17 cells: effector T cells with inflammatory properties","volume":"19","author":"Korn","year":"2007","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib26","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.4049\/jimmunol.177.7.4810","article-title":"A role for inflammatory mediators in the induction of immunoregulatory B cells","volume":"177","author":"Matsumura","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2353\/ajpath.2006.060079","article-title":"Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis","volume":"169","author":"Wolf","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib28","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1158\/0008-5472.CAN-07-6132","article-title":"Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists","volume":"68","author":"Sreevidya","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2010.10.008_bib29","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.1073\/pnas.0603119103","article-title":"Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor","volume":"103","author":"Walterscheid","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2010.10.008_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(93)90087-X","article-title":"Interference of the PAF receptor antagonist, PCA-4248, with the rat pleurisy evoked by inflammatory mediators or allergen","volume":"237","author":"Martins","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib31","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2010.10.008_bib32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1523-1747.1998.00347.x","article-title":"Interleukin-17 and interferon-\u03b3 synergize in the enhancement of proinflammatory cytokine production by human keratinocytes","volume":"111","author":"Teunissen","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib33","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1038\/jid.2009.88","article-title":"Inflammatory skin disease in K5.hTGF-\u03b21 transgenic mice is not dependent on the IL-23\/Th17 inflammatory pathway","volume":"129","author":"Fitch","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1523-1747.2000.00058.x","article-title":"Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production","volume":"115","author":"Countryman","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib35","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1172\/JCI118142","article-title":"Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis","volume":"96","author":"Bussolino","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2010.10.008_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2133.1985.tb04855.x","article-title":"Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (PAF-acether) in man","volume":"112","author":"Archer","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2010.10.008_bib38","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.4049\/jimmunol.160.8.3783","article-title":"A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression","volume":"160","author":"Shreedhar","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib39","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4049\/jimmunol.168.5.2255","article-title":"Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions","volume":"168","author":"Harizi","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.taap.2003.07.014","article-title":"Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression","volume":"195","author":"Ramos","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib41","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1523-1747.1998.00444.x","article-title":"Treatment of psoriasis with interleukin-10","volume":"111","author":"Reich","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1523-1747.2001.01248.x","article-title":"Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8\/CXCR2 pathway and normalization of keratinocyte maturation","volume":"116","author":"Reich","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jaad.2004.04.029","article-title":"Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA","volume":"51","author":"Legat","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib44","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1073\/pnas.0600666103","article-title":"Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2010.10.008_bib45","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","article-title":"Stat3 and Stat4 direct development of IL-17-secreting Th cells","volume":"178","author":"Mathur","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2010.10.008_bib47","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1073\/pnas.0910371106","article-title":"Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling","volume":"106","author":"Pflegerl","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2010.10.008_bib48","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/j.molimm.2008.06.029","article-title":"IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants","volume":"45","author":"de Paus","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib49","doi-asserted-by":"crossref","first-page":"24113","DOI":"10.1074\/jbc.M100720200","article-title":"G-protein-independent activation of Tyk2 by the platelet-activating factor receptor","volume":"276","author":"Lukashova","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2010.10.008_bib50","doi-asserted-by":"crossref","first-page":"21237","DOI":"10.1074\/jbc.M110955200","article-title":"Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells: evidence for a dual kinase mechanism","volume":"277","author":"Deo","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2010.10.008_bib51","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1074\/jbc.M304497200","article-title":"Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells","volume":"279","author":"Deo","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2010.10.008_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2230.1994.tb01246.x","article-title":"The effect of topical application of the platelet-activating factor-antagonist, Ro 24\u20130238, in psoriasis vulgaris: a clinical and immunohistochemical study","volume":"19","author":"Elbers","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1468-3083.2006.01830.x","article-title":"Severe psoriasis pustulosa palmaris et plantaris (Barber-Konigsbeck) treated successfully with soluble tumour necrosis factor receptor fusion protein (etanercept)","volume":"21","author":"Kasche","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib54","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1365-2133.2007.07829.x","article-title":"Two years of experience with etanercept in recalcitrant psoriasis","volume":"156","author":"Ahmad","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000134613","article-title":"Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade)","volume":"217","author":"Thielen","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.ajpath.2010.10.008_bib56","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/120347540400800404","article-title":"Successful treatment of Von Zumbusch pustular psoriasis with infliximab","volume":"8","author":"Trent","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ajpath.2010.10.008_bib57","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2010.10.008_bib58","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1523-1747.2003.12085.x","article-title":"High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients","volume":"120","author":"Kreimer-Erlacher","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib59","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/j.1365-2133.2007.08190.x","article-title":"Psoriasis patients show signs of insulin resistance","volume":"157","author":"Boehncke","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib60","doi-asserted-by":"crossref","first-page":"1150.e1","DOI":"10.1016\/j.amjmed.2009.06.021","article-title":"Comorbidities in patients with psoriasis","volume":"122","author":"Gottlieb","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.ajpath.2010.10.008_bib61","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jid.2009.55","article-title":"Complexity of the association between psoriasis and comorbidities","volume":"129","author":"Nijsten","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ijo.2008.216","article-title":"Increased activity of interleukin-23\/interleukin-17 proinflammatory axis in obese women","volume":"33","author":"Sumarac-Dumanovic","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ajpath.2010.10.008_bib63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molimm.2008.12.032","article-title":"Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet","volume":"47","author":"Pejnovic","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajpath.2010.10.008_bib64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/emm.2004.30","article-title":"Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation","volume":"36","author":"Rasheed","year":"2004","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ajpath.2010.10.008_bib65","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1053-2498(98)00073-4","article-title":"Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds","volume":"18","author":"Crawford","year":"1999","journal-title":"J Heart Lung Transplant"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401000101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401000101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:57:10Z","timestamp":1757599030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294401000101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S000294401000101X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2010.10.008","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-Activating Factor Blockade Inhibits the T-Helper Type 17 Cell Pathway and Suppresses Psoriasis-Like Skin Disease in K5.hTGF-\u03b21 Transgenic Mice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2010.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}